Literature DB >> 14981939

Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines.

Cecilia G Bredin1, Zhiwen Liu, Julius Klominek.   

Abstract

Growth factors secreted by either host or tumour cells play a major role in tumour cell progression. Besides stimulating cell division, growth factors may also stimulate cell migration and modulate matrix metalloprotease (MMP) production. MMPs are enzymes involved in a variety of physiological and pathological processes including tumour cell invasion and metastasis. We have previously shown that different growth factors regulate the motile behaviour of human lung cancer cell lines. In order to further advance our knowledge of the role the different growth factors play in lung cancer, we investigated their effect on two key enzymes belonging to the MMP family of enzymes, namely MMP-9 and MMP-2. Serum-free cultures of three human non-small cell lung cancer cell lines were exposed to five different growth factors: insulin-like growth factor I (IGF I) and II (IGF II), hepatocyte growth factor (HGF), epidermal growth factor (EGF) and stem cell factor (SCF). The expression of MMP-9 and MMP-2 in growth factor-treated and untreated cell lines was evaluated using gelatine zymography and quantified using computer-assisted image analyses. We found heterogeneous expression and activity of MMP-9 and MMP-2 in all three lung cancer cell lines. The most important finding in our study is that HGF and EGF are capable of stimulating the conversion of MMP-9 from a latent to an active form in human large cell lung cancer cell line U-1810 [corrected]. IGF I, IGF II, HGF and EGF stimulated an enhanced expression and activity of the latent form of MMP-2 and MMP-9. SCF did not enhance MMP activity in any of the cell lines tested. Our previous studies have shown that IGF I, IGF II, HGF, EGF and SCF induce migration of human non-small cell lung cancer cells in the presence of extracellular matrix (ECM) components. In the present study we show that growth factors can also enhance the expression of MMP's in these cells. Taken together these results indicate that certain growth factors may promote invasiveness through their ability to induce not only cell migration, but also by enhancing the expression and activity of matrix degrading MMP-2 and MMP-9.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14981939

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Endothelial PAS domain-containing protein 1 confers TKI-resistance by mediating EGFR and MET pathways in non-small cell lung cancer cells.

Authors:  Qiang Zhen; Jun-Feng Liu; Jia-Bao Liu; Ren-Feng Wang; Wei-Wei Chu; Ya-Xiao Zhang; Guo-Liang Tan; Xiao-Jian Zhao; Bao-Lei Lv
Journal:  Cancer Biol Ther       Date:  2015-04-01       Impact factor: 4.742

Review 2.  MET targeted therapy for lung cancer: clinical development and future directions.

Authors:  Yan Feng; Patrick C Ma
Journal:  Lung Cancer (Auckl)       Date:  2012-08-09

3.  Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3).

Authors:  M R Vijayababu; A Arunkumar; P Kanagaraj; P Venkataraman; G Krishnamoorthy; J Arunakaran
Journal:  Mol Cell Biochem       Date:  2006-04-28       Impact factor: 3.396

4.  Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.

Authors:  Jasti S Rao; Christopher Gondi; Chandramu Chetty; Subramanyam Chittivelu; Pushpa A Joseph; Sajani S Lakka
Journal:  Mol Cancer Ther       Date:  2005-09       Impact factor: 6.261

5.  Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells.

Authors:  L Xu; M B Nilsson; P Saintigny; T Cascone; M H Herynk; Z Du; P G Nikolinakos; Y Yang; L Prudkin; D Liu; J J Lee; F M Johnson; K-K Wong; L Girard; A F Gazdar; J D Minna; J M Kurie; I I Wistuba; J V Heymach
Journal:  Oncogene       Date:  2010-02-15       Impact factor: 9.867

6.  Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expression.

Authors:  Pauli Puolakkainen; Aino Koski; Sanna Vainionpää; Zhanlong Shen; Heikki Repo; Esko Kemppainen; Harri Mustonen; Hanna Seppänen
Journal:  Med Oncol       Date:  2014-02-14       Impact factor: 3.064

7.  Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism.

Authors:  N Théou-Anton; S Tabone; D Brouty-Boyé; R Saffroy; L Ronnstrand; A Lemoine; J-F Emile
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

8.  Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer.

Authors:  Zhigang Wang; Zheng Wang; Zhu Liang; Jikuan Liu; Weicheng Shi; Peiru Bai; Xialu Lin; Ruth Magaye; Jinshun Zhao
Journal:  Onco Targets Ther       Date:  2013-10-16       Impact factor: 4.147

Review 9.  Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?

Authors:  Xiangdong Wang; Ka Li; Hong Chen; Diane Wang; Yong Zhang; Chunxue Bai
Journal:  J Cell Mol Med       Date:  2010-01-30       Impact factor: 5.310

10.  MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion/metastasis.

Authors:  Ming-Yi Ho; Chi-Ming Liang; Shu-Mei Liang
Journal:  Oncotarget       Date:  2015-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.